|
After more than a year out in the cold, the programme’s reauthorisation is a boost for rare disease therapy developers.
|
 |
|
FDA commissioner Marty Makary’s pledge came after Hims & Hers launched a compounded version of Novo’s Wegovy pill.
|
|
|
The site will act as a global hub for cancer research as the UK looks to maintain its competitiveness in the life sciences market.
|
|
|
The company projects 2026 revenues between $46.0bn and $47.5bn, with non-GAAP EPS ranging from $6.05 to $6.35.
|
|
|
Eisai will now take ownership of the Japanese rights to differentiated anti-PD-1 therapy, Hetronifly.
|
|
|
Apotex’s Searchlight Pharma will seek marketing authorisation and manage commercialisation activities for Nebido in Canada.
|
|
